Korean Stock

FSS DART Disclosures
전체 공시 보기
거래소 Daewoong Pharma
★★
Completion of Licensor Succession for mRNA-based ERA Platform Technology Transfer Agreement (Total USD 239M)
수신일자: 4h ago
거래소 Hanall Biopharma
★
Conditional License Agreement for mRNA-based ERA Platform… Total $239M
수신일자: 4h ago
거래소 Daewoong
★★★★
Completion of Succession of Licensor Position for mRNA ERA Technology... Securing Right to Receive Up to $239M
수신일자: 4h ago
지분 Barunson Entertainment & Arts
★
4:1 Stock Consolidation Reduces Major Shareholder's Holdings by 14,255,250 Shares… Ownership Drops to 25.53%
수신일자: 4h ago
지분 Jolse
★
3:1 Reverse Stock Split Reduces CEO Moon's Holdings from 376,881 to 125,627 Shares, Stake Drops to 1.07%
수신일자: 4h ago
지분 09women
★★★
Change of Control at 72 Billion KRW with Premium of 7,200 KRW per Share
수신일자: 4h ago
기타 09women
★
Company name change and business expansion, director compensation limit approved at 2 billion won, CB/BW issuance limit raised to 100 billion won
수신일자: 4h ago
거래소 Fantagio
★
Disclosure on Completion and Plan of Largest Shareholder's Mandatory Holding
수신일자: 4h ago
거래소 AXBIS
★
KRW 8 Billion Contract for Laser System for Secondary Battery (Prismatic) Manufacturing Process
수신일자: 4h ago
거래소 APTN
★★★
Conversion Price Plunges from 7,050 to 1,870 Won; 6.6 Million Additional Shares
수신일자: 4h ago